Cortechs.ai | Restriction Spectrum Imaging (RSI) improves cancer detection
Contact

Restriction Spectrum Imaging (RSI) improves cancer detection

  • Category: Published research
  • Product: OnQ Prostate
  • Disease: Prostate cancer

Compares the diagnostic performance of restriction spectrum imaging (RSI), with that of conventional multi-parametric (MP) magnetic resonance imaging (MRI) for prostate cancer (PCa) detection in a blinded reader-based format. 2016.

[button]Download[/button]

  • Topic: Published research

More Resources

Cortechs.ai | Cortechs.ai Receives Health Canada Approval to Expand Sales of AI-Powered Imaging Solutions in North America
  • 2 mins

04/22/2025

Cortechs.ai Receives Health Canada Approval to Expand Sales of AI-Powered Imaging Solutions in North America

Cortechs.ai receives Health Canada approval to expand its AI imaging solutions into Canada, advancing diagnostic precision and patient care.

,

Cortechs.ai | Pediatric Neuroimaging Insights: The NeuroQuant® Age Range Series
  • 3 mins

04/02/2025

Pediatric Neuroimaging Insights: The NeuroQuant® Age Range Series

Brain volumetrics play a pivotal role in understanding pediatric neurological development. Explore how NeuroQuant® enhances neuroimaging from ages 3 to 100.

Cortechs.ai | How NeuroAlign CT Subtraction Maps Enhance Detection and Confidence in Neuroradiology
  • 5 mins

03/31/2025

How NeuroAlign CT Subtraction Maps Enhance Detection and Confidence in Neuroradiology

What if head CT assessment could be even faster and more accurate? Subtraction maps allow for improved detection and visualization of subtle interval changes.

Cortechs.ai | Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India
  • 2 mins

03/27/2025

Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India

We are pleased to announce a strategic partnership with Kryptonite Solutions to distribute our innovative portfolio across India.

Cortechs.ai | Cortechs.ai Announces Strategic Distribution Partnership with Medical Horizons to Expand Presence in Italy, Turkey, and the Middle East
  • 2 mins

03/20/2025

Cortechs.ai Announces Strategic Distribution Partnership with Medical Horizons to Expand Presence in Italy, Turkey, and the Middle East

We are pleased to announce a strategic distribution partnership with Medical Horizons, a premier AI-powered medical device distributor based in Florence, Italy.

Cortechs.ai | Unlocking the Power of AI Imaging in Multiple Sclerosis: How NeuroQuant® MS Enhances Lesion Detection and Monitoring
  • 2 mins

03/18/2025

Unlocking the Power of AI Imaging in Multiple Sclerosis: How NeuroQuant® MS Enhances Lesion Detection and Monitoring

Unlock the power of AI-driven imaging with NeuroQuant® MS—enhancing lesion detection, monitoring, and personalized care for Multiple Sclerosis.

View our insights
Cortechs.ai | Restriction Spectrum Imaging (RSI) improves cancer detection
Cortechs.ai | Restriction Spectrum Imaging (RSI) improves cancer detection

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

Cortechs.ai | Restriction Spectrum Imaging (RSI) improves cancer detection
  • Solutions
  • © Cortechs.ai 2024
Scroll to Top